APGE

APGE Stock-Based Compensation

$57.63MTTM · USD

Period ending:

APGE FY Stock-Based CompUSD
APGE FY Stock-Based Comp2022-12-31: $2.14M2023-12-31: $6.10M2024-12-31: $23.33M2025-12-31: $46.28M$46.28M$0.00
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

APGE stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Apogee Therapeutics Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
46,277,000
23,332,000
6,103,000
2,142,000

Compare stock-based compensation

All APGE financial metrics · APGE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.